Travere Therapeutic | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 1 22:03 ET
Travere Therapeutic | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 1 22:03 ET
Travere Therapeutic | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 1 22:03 ET
Travere Therapeutic | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 1 22:03 ET
Travere Therapeutic | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 1 12:47 ET
Travere Therapeutic | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 1 11:42 ET
Travere Therapeutic | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 1 09:56 ET
Travere Therapeutic | 144: Notice of proposed sale of securities pursuant to Rule 144
Jan 23 00:00 ET
Travere Therapeutic | 144: Notice of proposed sale of securities pursuant to Rule 144
Jan 23 00:00 ET
Travere Therapeutic | 144: Notice of proposed sale of securities pursuant to Rule 144
Jan 23 00:00 ET
Travere Therapeutic | 144: Notice of proposed sale of securities pursuant to Rule 144
Sep 5, 2023 12:54 ET
Travere Therapeutic | 144: Notice of proposed sale of securities pursuant to Rule 144
Sep 5, 2023 12:43 ET
Travere Therapeutic | 144: Notice of proposed sale of securities pursuant to Rule 144
Sep 5, 2023 12:34 ET
Travere Therapeutic | 144: Notice of proposed sale of securities pursuant to Rule 144
May 10, 2023 13:39 ET
Travere Therapeutic | 144: Notice of proposed sale of securities pursuant to Rule 144
May 10, 2023 12:58 ET
Travere Therapeutic | 424B5: Prospectus
Mar 1, 2023 17:14 ET
Travere Therapeutic | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Feb 28, 2023 19:45 ET
Travere Therapeutic | 424B5: Prospectus
Feb 27, 2023 17:05 ET
Travere Therapeutic | 424B5: Prospectus
Mar 9, 2022 16:20 ET
Travere Therapeutic | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Mar 9, 2022 16:08 ET
No Data
No Data